These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 19226377)

  • 1. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
    Burns TF; Bernhard EJ; El-Deiry WS
    Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
    Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of apoptosis and the related genes in non-alcoholic steatohepatitis].
    Nan YM; Wu WJ; Yao XX; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):41-6. PubMed ID: 17244458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
    Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
    Yamazaki Y; Kakizaki S; Horiguchi N; Sohara N; Sato K; Takagi H; Mori M; Negishi M
    Gut; 2007 Apr; 56(4):565-74. PubMed ID: 16950832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
    dela Peña A; Leclercq IA; Williams J; Farrell GC
    J Hepatol; 2007 Feb; 46(2):304-13. PubMed ID: 17157947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress.
    Kokkinakis DM; Liu X; Chada S; Ahmed MM; Shareef MM; Singha UK; Yang S; Luo J
    Cancer Res; 2004 Oct; 64(20):7513-25. PubMed ID: 15492278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
    Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
    Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
    Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ
    Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation.
    Tashiro H; Itamoto T; Ohdan H; Arihiro K; Tateaki Y; Nakahara H; Ochi M; Hino H; Mizunuma K; Hara H; Tokita D; Onoe T; Ishiyama K; Mitsuta H; Sugino K; Asahara T
    Transpl Int; 2004 Nov; 17(10):626-33. PubMed ID: 15502938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
    Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC
    Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific induction of p53 targets in vivo.
    Fei P; Bernhard EJ; El-Deiry WS
    Cancer Res; 2002 Dec; 62(24):7316-27. PubMed ID: 12499275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
    Hinz S; Trauzold A; Boenicke L; Sandberg C; Beckmann S; Bayer E; Walczak H; Kalthoff H; Ungefroren H
    Oncogene; 2000 Nov; 19(48):5477-86. PubMed ID: 11114725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
    Leclercq IA; Farrell GC; Sempoux C; dela Peña A; Horsmans Y
    J Hepatol; 2004 Dec; 41(6):926-34. PubMed ID: 15582125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.